When considering strong uPAR expression (score > 3), Sensitivity and Specificity in the NSCLC cohort were equal to 0.34 (95% C.I. 0.25 to 0.43) and 0.90 (95% C.I. 0.84 to 0.96). Here, PLAUR is linked to non-small cell lung carcinoma.